[ET Net News Agency, 14 December 2017] WuXi Biologics (02269) said one of its
controlling shareholders, WuXi Biologics Holdings Limited, agreed to place 126 million
shares, representing around 10.83% of the issued share capital, to independent parties at
HK$40.25 each.
Biologics Holdings will repurchase its own shares from its shareholders who will receive
proceeds from the placing, including WuXi PharmaTech (Cayman) Inc. and G&C V Limited (an
entity indirectly and jointly owned by Ge Li and Ning Zhao.
In addition, a total of about 1.73 million shares, representing around 0.15% of the
issued share capital of WuXi Biologics, will be transferred by way of share repurchase
from Biologics Holdings to G&C VI Limited, an entity indirectly and wholly-owned by Ge Li,
the Chairman of WuXi Biologics. Li has directed these shares to be immediately donated to
the Ge Li and Ning Zhao Family Foundation, a donor-advised fund established for the
benefit of non-profit organizations, with a special emphasis on healthcare and education.
Upon completion, the shareholding held by Biologics Holdings in WuXi Biologics will
decrease from about 73.55% to about 62.57%, and Biologics Holdings will remain as a
controlling shareholder, Li will control about 22.77% of the issued share capital of
Biologics Holdings and 59.58% of the voting power at its general meetings, and other
investors, through their shareholding interest in WuXi PharmaTech, will control 77.23% of
the issued share capital of Biologics Holdings and 40.42% of the voting power at its
general meetings. (HL)